Clinical Studies Overview

Actions

 

Clinical Studies

Magmaris Clinical Trials



 

Study Name Study Type Patients Status 1° Endpoint
BIOSOLVE-II FIM 123 36m FUP available In-segment LLL at 6 months
BIOSOLVE-III Pivotal Trial 61 24 FUP available In-hospital Procedural Success
BIOSOLVE-II-III Pivotal Trial 180 24m FUP available BIOSOLVE-II: In-segment LLL at 6-month
BIOSOLVE-III:Procedure Success
BIOSOLVE-IV PMS Registry 2054 12 FUP on first 400 patients available BIOSOLVE TLF (composite of CD, TV-MI and TLR) at 12 months



Previous Generations Clinical Trials


 

Study Name Study Type Patients Status 1° Endpoint
BIOSOLVE-I FIM 46 completed TLF (composite of CD, TV-MI and cd-TLR) at 6 and 12 months
PROGRESS FIM 63 completed Composite of CD, non-fatal MI and cd-TLR at 4 months

${loading}